Speaker line-up of 2023

Alexandra Cameron
Senior Expert, Impact Initiatives and Research Coordination, Antimicrobial Resistance Division, World Health Organization

Bernhard Kerscher
Head of Laboratory & Preclinical Assessor, Paul-Ehrlich-Institut - German Federal Institute for Vaccines and Biomedicines

Chantal Morel
Health economist in anti-microbial resistance, KPM Center for Public Management, University of Bern

Christoph Dehio
Full Professor of Molecular Microbiology, Director of National Centre of Competence in Research (NCCR) “AntiResist”

Cornelis Boersma
Professor Sustainable Health and Innovation, Netherlands Antibiotic Development Platform (NADP)

Dominik Gary
Chief Development Officer, fzmb GmbH - Research Center for Medical Technology and Biotechnology

Giancarlo Biagini
Head of the Department of Tropical Disease Biology, Liverpool School of Tropical Medicine

Jan Poolman
Vice-President, Head Bacterial Vaccine Discovery and Early Development, Janssen Vaccines & Prevention B.V.

Kamini Walia
Senior Scientist at Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research

Kevin Outterson
Austin B Fletcher Professor, Boston University, and Executive Director & Principal Investigator, CARB-X

Mark Jones, PhD PMP
Head of Development, Basilea Pharmaceutica International Ltd | BEAM Alliance - Board Member | Swiss Round Table for Antibiotics - Board Member

Morgane Vanbiervliet
Manager, Market Intelligence & Business Development, Infectious Diseases, Debiopharm International SA

Norbert Heinrich
Unit head for TB diagnostic and treatment trials, Ludwig-Maximilians-University of Munich

Rakel Arrazuria
Researcher, Microbiology Division, Paul-Ehrlich-Institut - German Federal Institute for Vaccines and Biomedicines

Santiago Ferrer Bazaga
Investigator and Scientific Advisor for Drug Discovery, Universidad Carlos III de Madrid

Tetsuya Itani
Director, Office of Global Health Cooperation, Ministry of Health, Labour and Welfare, Japan

Zemer Gitai
EG Conklin Professor, Department of Molecular Biology, Princeton University and Founder, ArrePath Inc.